Sitemap
Pages
- Leadership (July 16, 2020)
- Bioanalytical Science (July 17, 2020)
- About Synexa (July 21, 2020)
- Contact (July 22, 2020)
- Biomarker Science (July 28, 2020)
- Research and Development (July 29, 2020)
- Pharmacokinetics (August 4, 2020)
- Immunogenicity (August 4, 2020)
- SynErgy (August 20, 2020)
- Operations (June 7, 2021)
- Bioanalysis (June 8, 2021)
- Tech Platforms (June 8, 2021)
- Prototrials (June 9, 2021)
- Home (June 11, 2021)
- Solutions for Clinical Research (June 11, 2021)
- Biomarker Solutions (June 11, 2021)
- Custom Solutions & Novel Modalities (June 14, 2021)
- Therapeutic Expertise (June 14, 2021)
- Privacy Policy (July 2, 2021)
- Careers (August 25, 2021)
- News (November 2, 2021)
- PBMC Isolation (November 11, 2021)
- Flow Cytometry Services (November 11, 2021)
- Webinars (December 1, 2021)
- Privacy (February 11, 2022)
- Cookie-policy (February 11, 2022)
- Terms of use (February 11, 2022)
- Executive Board (May 11, 2022)
- Non-Executive Team (May 11, 2022)
- Synexa Team (May 19, 2022)
- Contact Sales (May 27, 2022)
- Submit RFI/RFP (May 30, 2022)
- Career Enquiries (May 30, 2022)
- General Enquiries (June 6, 2022)
- Sitemap (September 9, 2022)
- Events (February 17, 2023)
- Thank you (June 8, 2023)
- Impressum (June 9, 2023)
Blog Articles
- A unifying expression signature for SLE (July 16, 2020)
- Complement C4 Genes and Sex-Biased Disease Susceptibility (July 16, 2020)
- Potential concussion biomarkers discovered in circulating blood after brain injury (July 16, 2020)
- Immune checkpoint inhibitors and MDSCs (July 16, 2020)
- Faecal Calprotectin as a biomarker in Crohn’s disease (July 24, 2020)
- Immune biomarkers in depression (July 24, 2020)
- Rapid expansion of Treg cells protects from collateral colitis following a viral trigger (September 18, 2020)
- The prospect of immunotherapy for combating Alzheimer’s disease (September 18, 2020)
- Macrophages transfer mitochondria to sensory neurons to resolve inflammatory pain (September 18, 2020)
- Spot on: Use of Dried Blood Spots (DBS) for serological immunoassays (September 18, 2020)
- Th17 Cells and IL-17: a possible link between inflammation and neuronal decline in Multiple Sclerosis (September 18, 2020)
- Infertility and the importance of the endometrial immune balance (February 15, 2021)
- The Biomarker Association between Depression and Vascular Disease (February 15, 2021)
- Synexa raises awareness for Rare Diseases Day (February 28, 2022)
- Lipids as Biomarkers of Brain Disorders (March 24, 2022)
- Fibrosis and SMAD signalling (April 22, 2022)
- A Quick Guide to Biomarker Solutions (August 3, 2022)
- Where Does Bioanalysis Fit into Drug Discovery Pipelines? (August 19, 2022)
- How to Accelerate Pre-Clinical Trials with Flow Cytometry (September 21, 2022)
- How to Measure Bacteriophages in Clinical Studies for Antimicrobial Agents (September 30, 2022)
- Enhancing PCR Molecular Diagnostics Using Immunoassays (October 7, 2022)
- A Brief Introduction To Novel Modalities (November 2, 2022)
- Using Exosomes As Clinical Biomarkers (November 18, 2022)
- How Immunogenomics Factors into Cell and Gene Studies (November 29, 2022)
- What Biomarkers Are Used For CNS Drug Development? (February 9, 2023)
- Understanding the Role of Phenotypic Assays in Drug Research (February 24, 2023)
- How Cytokine Release Assays Work in Predictive Immunotoxicology (March 10, 2023)
- The Current State of Tuberculosis Research | World TB Day (March 24, 2023)
- Parkinson’s Disease Biomarker Assessment: New Approaches and Directions (April 11, 2023)
- Improving the World’s First Malaria Vaccine (April 26, 2023)
- Monitoring Immune Response in Pediatric Vaccine Recipients (April 27, 2023)
- Asthma Care for All (May 2, 2023)
- Biomarkers for Dementia (May 17, 2023)
- Challenges and Opportunities: Development of the HIV vaccine (May 18, 2023)
Feature Articles
- Lack of implantation of an embryo: when the numbers count (July 23, 2020)
- SARS CoV-2: when does the calm become the perfect storm? (July 24, 2020)
- NanoString nCounter Technology – COVID-19 Immunological and Inflammatory Response (October 2, 2020)
- Immunogenicity 101: Antidrug Antibodies, Neutralizing Antibodies, and everything in between (January 20, 2021)
- Behind the wave (May 20, 2021)
Brochures
webinars
- Overcoming challenges to COVID-19 clinical trials (July 27, 2021)
- Alternative Approaches to Functional and Phenotypic Assays Using Multiparameter Flow Cytometry (August 1, 2022)
- Clinically Relevant Biomarker Strategies and Machine Learning for Biomarker Assessment (December 1, 2022)
- Accelerating TB Vaccine Development: Insights from Microsampling, Biomarkers and Data Analysis (May 18, 2023)
Datasheets
News
- Synexa Announces Tripartite Collaboration (March 23, 2021)
- Synexa Life Sciences Co-founder and CEO to become company’s Chairman (May 13, 2022)
- Synexa Life Sciences announces strategic growth plans and strengthening of its executive team (May 18, 2022)
- Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities (May 19, 2022)
- Synexa Life Sciences expands operations in North America with new Rockville laboratory site (June 13, 2022)
- Synexa Life Sciences to appoint Chief Commercial Officer to support company growth ambitions (August 19, 2022)
- Synexa Life Sciences celebrates its 20th anniversary (March 3, 2023)
- Synexa Life Sciences Joins CEPI in Advancing Global Epidemic Preparedness and Response (May 30, 2023)
